Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2008-04-08
2008-04-08
Le, Long V. (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C530S332000, C530S840000
Reexamination Certificate
active
07354723
ABSTRACT:
Disclosed are compositions and methods for performing an immuno-assay that includes measuring the amount of an isomerised or optically inverted non-collagen protein derived from cartilage.
REFERENCES:
patent: 2003/0216319 (2003-11-01), Cloos et al.
patent: WO 96/30765 (1996-10-01), None
patent: WO 98/08098 (1998-02-01), None
patent: WO 98/26286 (1998-06-01), None
patent: WO 01/13110 (2001-02-01), None
Harlow and Lane, “Antibodies: A Laboratory Manual,” Cold Spring Harbor Laboratory, 1988, Chapter 5, p. 76.
Burgess et al. J Cell Bio. 111:2129-2138, 1990.
Lazar et al. Molecular and Cellular Biology 8:1247-1252 (1988).
Tao et al., The Journal of Immunology, 143:2595-2601 (1989).
Biology-Online.org Online Dictionary, definition of “isomer.”, 2005.
Garnero et al. “Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage” (2001) Ann Rheum Dis 60:619-626.
Garnero et al. “Biochemical markers of joint tissue turnover in early rheumatoid arthritis” (2003) Clin Exp Rheumatol 21(5 Suppl 31):S54-S58.
A Laboratory Manual, E. Harlow and D. Lane, ed., Cold Spring Harbor Laboratory (Cold Spring Harbor, NY, 1988), p. 76.
Janeway et al., Immunobiology: The Immune System in Health and Disease, Fourth Edition, 1999: Elsevier Science Ltd/Garland Publishing, London, UK, pp. 34-35, 46-47, and 599.
D'Amico et al. “Pathophysiology of proteinuria” Kidney International, vol. 63 (2003), pp. 809-825.
Skoumal et al. (2004) Arthritis Res Ther 6:73-74.
Roughley, P.J. and El-Maadaway, S., “The Use of Biochemical Markers of Bone and Cartilage Metabolism to Monitor Osteoarthritis-Dreams and Reality” The Journal of Rheumatology 30:5, p. 910-912, 2003.
Poole, R. “Can Serum Biomarker Assays Measure the Progression of Cartilage Degeneration in Osteoarthritis?” Arthritis & Rheumatism 46:2549-2552, 2002.
Garnero et al. “Association of Baseline Levels of Markers of Bone and Cartilage Degradation with Long-Term Progression of Joint Damage in Patients with Early Rheumatoid Arthritis” Arthritis & Rheumatism 46:2847-2856, 2002.
Moller, H. J. “Connective Tissue Markers Of Rheumatoid Arthritis”, Scand. J. Clin. Lab. Invest. 1998, 58: 269-278.
Stucki, G., et al. “Management Of Rheumatoid Arthritis”, 1997, Current Opinion in Rheumatology, 9: 229-235.
Morein, B., et al. “Iscom, A Novel Structure For Antigenic Presentation Of Membrane Proteins From Enveloped Viruses”, Nature, vol. 308, (Mar. 29, 1984), pp. 457-460.
Goding, J. W., “Production Of Monoclonal Antibodies: Principles And Practice”, (1986), pp. 59-103.
Ishikawa, E., et al. “Enzyme-Labeling Of Antibodies And Their Fragments For Enzyme Immunoassay And Immunohistochemical Staining”, Journal of Immunoassay, 4(3), (1983), pp. 209-327.
Hermanson, Greg T. “Bioconjugate Techniques” 1996, Academic Press, San Diego, USA, pp. 193-196.
Neidhart, M., et al. “Small Fragments Of Cartilage Oligomeric Matrix Protein In Synovial Fluid And Serum As Markers F Cartilage Degradation”, British Journal Of Rheumatology 1997, vol. 36, pp. 1151-1160.
Lorenzo, P., et al. “A Novel Cartilage Protein (CILP) Present In The Mid-Zone Of Human Articular Cartilage Increases With Age”, J. Biol. Chem. , vol. 273, No. 36, Issue of Sep. 4, 1998, pp. 23463-23468.
Lorenzo, P., et al. “Cloning And Deduced Amino Acid Sequence Of A Novel Cartilage Protein (CILP) Identifies A Proform Including A Nucleotide Pyrophosphohydrolase”, J. Biol. Chem., vol. 273, No. 36, Issue of Sep. 4, 1998, pp. 23469-23475.
Kohler, G., et al. “Continuous Cultures Of Fused Cells Secreting Antibody Of Predefined Specificity”, Nature, vol. 256, Aug. 7, 1975, pp. 495-497.
Rosenquist, C., et al. “Serum Crosslaps One Step ELISA. First Application Of Monoclonal Antibodies For Measurement In Serum Of Bone-Related Degradation Products From C-Terminal Telopeptides Of Type I Collagen”, Clinical Chemistry (1998), vol. 44, No. 11, pp. 2281-2289.
Kearney, J. F., et al. “A New Mouse Myeloma Cell Line That Has Lost Immunoglobulin Expression But Permits The Construction Of Antibody-Secreting Hybrid Cell Lines”, Journal of Immunology, vol. 123, No. 4 , Oct. 1979, pp. 1548-1550.
Maroudas. A., et al. “Aggrecan Turnover In Human Articular Cartilage: Use Of Aspartic Acid Racemization As A Marker Of Molecular Age”, Archives Of Biochemistry And Biophysics, vol. 350, No. 1, Feb. 1, 1998, pp. 61-71.
Hughes, C. E., et al. “Monoclonal Antibodies That Specifically Recognize Neoepitope Sequences Generated by ‘Aggrecanase’ And Matrix Metalloproteinase Cleavage Of Aggrecan: Application To Catabolism In Situ And In Vitro”, J. Biochem, (1995), vol. 305, pp. 799-804.
Saxne, T., et al. “Cartilage Oligomeric Matrix Protein: A Novel Marker Of Cartilage Turnover Detectable In Synovial Fluid And Blood”, British Journal Of Rheumatology 1992, vol. 31, pp. 583-591.
Wollheim F.A. “Predictors Of Joint Damage In Rheumatoid Arthritis”, 1996, APMIS 104: 81-93.
Geiger, T., et al. “Deamidation, Isomerization, And Racemization At Asparaginyl And Aspartyl Residues In Peptides”, J. Biol. Chem. , vol. 262, No. 2, Jan. 15, 1987, 785-794.
Clarke, S. “Propensity For Spontaneous Succinimide Formation From Aspartyl And Asparaginyl Residues In Cellular Proteins”, Int. J. Peptide Protein Res.. 30: 1987, 808-821.
Poole, A. R., et al. “Biological Markers In Rheumatoid Arthritis”, Seminars In Arthritis And Rheumatism, vol. 23, No. 6, Suppl 2 Jun. 1994, pp. 17-31.
Fledelius, C. , et al. “Characterization Of Urinary Degradation Products Derived From Type I Collagen”, J. Biol. Chem., vol. 272, No. 15, Apr. 11, 1997, pp. 9755-9763.
Glant, T., et al. “Progressive Polyarthritis Induced In BALB/c Mice By Aggrecan From Normal And Osteoarthritic Human Cartilage”, Arthritis & Rheumatism, vol. 41, No. 6. Jun. 1998, pp. 1007-1018.
Dudhia, J., et al. “Age-Related Changes In The Content Of The C-Terminal Region Of Aggrecan In Human Articular Cartilage”, Biochem. J. 313, 1996, pp. 933-940.
Zhang, Y., et al. “Induction Of Arthritis In BALB/c Mice By Cartilage Link Protein”, Amer. Journal Of Pathology, vol. 153, No. 4, Oct. 1998, pp. 1283-1291.
Radkiewicz, J. L., et al. “Accelerated Racemization Of Aspartic Acid And Asparagine Residues Via Succinimide Intermediates: An Ab Initio Theoretical Exploration Of Mechanism”, J. Amer. Chem. Soc. ,1996, 118, pp. 9148-9155.
Rafferty, B., et al. “Pharmacokinetic Evaluation Of Superactive Analogues Of Growth Hormone-Releasing Factor (1-29)-Amide”, Peptides, vol. 9, pp. 207-209, 1988.
Van Regenmortel, M., et al. “D-Peptides As Immunogens And Diagnostic Reagents”, Current Opinion In Biotechnology, vol. 9: , pp. 377-382, 1998.
Campbell, A.M. “Monoclonal Antibody And Immunosensor Technology”, Laboratory Techniques In Biochemistry And Molecular Biology, vol. 23 (1991), pp. 136-205.
Christgau Stephan
Cloos Paul A. C.
Henriksen Dennis B.
Butler Greg B.
Edwards Angell Palmer & & Dodge LLP
Foster Christine
Le Long V.
Nordic Bioscience Dagnostics A/S
LandOfFree
Assay of isomerised and/or optically inverted proteins and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Assay of isomerised and/or optically inverted proteins and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assay of isomerised and/or optically inverted proteins and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2796342